Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-12.90M
↑ 88% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
$-110.88M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-12.90M | +46.2% |
| 2024 | $-23.97M | +82.3% |
| 2023 | $-135.49M | +22.5% |
| 2022 | $-174.83M | +33.7% |
| 2021 | $-263.81M | -167.7% |
| 2020 | $-98.55M | -38.2% |
| 2019 | $-71.29M | +52.1% |
| 2018 | $-148.79M | -13.3% |
| 2017 | $-131.32M | -174.6% |
| 2016 | $-47.82M | - |